Pharmaceutical composition for preventing and treating liver cancer as well as preparation method and application thereof
NL2039582B1Active Publication Date: 2026-07-21MENGGE DU
3 Cites 0 Cited by
Patent Information
- Application Number
- NL2039582
- Authority / Receiving Office
- NL · NL
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-01-13
- Publication Date
- 2026-07-21
- Estimated Expiration
- 2045-01-13
Abstract
The present invention provides a pharmaceutical composition. for* preventing' and 'treating liver cancer as well as a preparation method and an application thereof. The present invention provides a pharmaceutical composition for preventing and treating liver cancer, including: Radix bupleuri, Radix scutellariae, Endothelium corneum gigeriae galli, Radix astragali, Cortex cinnamomi, Poria and isovalerylshikonin. In the pharmaceutical composition, the traditional Chinese medicine composition improves prevention and treatment effects on liver cancer by regulating qi movement, harmonizing the liver and stomach, invigorating the spleen and promoting diuresis, etc.; and. the isovalerylshikonin. with. toxicity' to liver cancer cells induces apoptosis of liver cancer cells, and inhibits proliferation, migration and invasion. of liver cancer cells. The pharmaceutical composition of the present invention can play a role in preventing and treating liver cancer under synergy by combining the traditional Chinese medicine composition with isovalerylshikonin, and the pharmaceutical composition has selective cytotoxicity to tumor cells.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof
CN101757598A
Pharmaceutical composition for preventing and treating liver injury and / or liver cancer as well as preparation method and application thereof
CN113384667A
Method for extracting isovaleryl shikonin from radix arnebiae seu lithospermi and application of isovaleryl shikonin in preparation of anti-liver
CN115160137A